Bausch Health Companies Inc BHC
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover BHC, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
Bausch Health to Announce First-Quarter 2024 Results on May 2
-
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
-
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
-
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
-
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
-
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
-
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
-
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
Trading Information
- Previous Close Price
- $8.66
- Day Range
- $8.43–8.78
- 52-Week Range
- $5.57–11.46
- Bid/Ask
- $8.36 / $8.72
- Market Cap
- $3.15 Bil
- Volume/Avg
- 2.2 Mil / 2.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 2.46
- Price/Sales
- 0.36
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 20,270
- Website
- https://www.bauschhealth.com
Comparables
Valuation
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Price/Earnings (Normalized) | 2.46 | 18.71 | 1.26 |
Price/Book Value | — | 0.76 | 0.52 |
Price/Sales | 0.36 | 1.23 | 0.35 |
Price/Cash Flow | 1.94 | 18.90 | 1.08 |
Price/Earnings
BHC
BLCO
ASRT
Financial Strength
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Quick Ratio | 0.68 | 0.74 | 1.30 |
Current Ratio | 1.30 | 1.74 | 1.83 |
Interest Coverage | 0.69 | 0.36 | −85.86 |
Quick Ratio
BHC
BLCO
ASRT
Profitability
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Return on Assets (Normalized) | 4.86% | 2.15% | −87.36% |
Return on Equity (Normalized) | — | 3.72% | −156.35% |
Return on Invested Capital (Normalized) | 10.43% | 4.42% | −128.46% |
Return on Assets
BHC
BLCO
ASRT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Smddygdqy | Cqlb | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Vyhjlbcbg | Cnvdpn | $68.1 Bil | |
HLN
| Haleon PLC ADR | Tsztvjd | Wwhx | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kqskvwnmm | Hnkk | $14.3 Bil | |
VTRS
| Viatris Inc | Wsrwjchpb | Mzck | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jnghptzx | Gkkyr | $12.0 Bil | |
CTLT
| Catalent Inc | Dcmcdtmy | Fsszqy | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Zvxbyyt | Lvlsz | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Nphvhtpn | Nhbm | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Cgdtcfsg | Kybhrn | $3.4 Bil |